While there were no significant differences in WHO-Fc and NT-proBNP between the two groups in our study, CTEPH patients had significantly decreased mPAP, PVR and higher oxygen pulse %pred. The gene discussed is NPPB; the disease is chronic thromboembolic pulmonary hypertension.